Physician profile
Alan Mitchel Berg
NPI 1992798920
$24,841.39
in general payments reported to CMS, 2019-2025
33 companies · $4,144 in 2025
The $4,144 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,844 · 2020: $7,269 · 2021: $1,145 · 2022: $1,586 · 2023: $3,871 · 2024: $2,983 · 2025: $4,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,973.85 |
| Travel and Lodging | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $10,049.21 | 2019-2025 | Veritas Vision System, Ifs Advanced Femtosec Laser, Catalys System |
| Glaukos Corporation | $5,893.67 | 2019-2025 | Kxl System (Not Refurbished), Ce-Marked Kxla System, Kxl1b-Ce-Marked Kxlsystem |
| Alcon Vision LLC | $4,687.13 | 2019-2025 | Clareon, Wavelight Ex500 Excimer Laser, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $550.26 | 2023-2025 | Envista Envy Iol, Stellaris, Envista Mx60 Iol |
| Staar Surgical Company | $440.13 | 2019 | |
| Eyevance Pharmaceuticals LLC | $386.85 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $352.05 | 2019-2023 | Cequa, Bromsite, Xelpros |
| Tarsus Pharmaceuticals, INC. | $312.47 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $282.91 | 2019-2020 | |
| Rxsight INC | $280.83 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Novartis Pharmaceuticals Corporation | $245.99 | 2019-2021 | |
| Amgen INC. | $216.83 | 2024-2025 | Tepezza |
| Abbvie INC. | $117.48 | 2022-2025 | Alphagan P, Lumigan, Vuity |
| Beaver-Visitec International, INC. | $108.87 | 2020 | |
| Carl Zeiss Meditec, INC. | $102.63 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $100.21 | 2023-2025 | Iyuzeh |
| Optos, INC. | $100.00 | 2019 | |
| Allergan, INC. | $85.81 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $64.31 | 2019-2021 | |
| Halozyme INC | $62.56 | 2021 | |
| Harrow Eye, LLC | $59.75 | 2025 | Vevye |
| Carl Zeiss Meditec USA, INC. | $52.84 | 2023 | Visumax |
| Dompe US, INC. | $46.78 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $39.83 | 2019 | |
| Shire North American Group INC | $31.74 | 2019 | |
| Mallinckrodt Hospital Products INC. | $27.64 | 2024 | Acthar |
| Rayner Intraocular Lenses Limited | $25.96 | 2024 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Mallinckrodt Enterprises LLC | $23.17 | 2019 | |
| Sight Sciences, INC. | $22.54 | 2023 | Omni Surgical System |
| Oyster Point Pharma, INC. | $21.68 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Ocular Therapeutix, INC. | $16.50 | 2022 | |
| Horizon Therapeutics Plc | $13.36 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.